{"id":"W3117867574","doi":"10.47326/ocsat.2021.02.06.1.0","title":"Rollout Strategy for the Pfizer-BioNTech COVID-19 Vaccine in Ontario","year":2020,"lang":"en","type":"report","venue":"","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Booster (rocketry); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Medicine; Booster dose; Neutralizing antibody; Antibody response; Virology; Antibody; Immunology; Internal medicine; Titer; Virus; Infectious disease (medical specialty); Outbreak; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001131947,0.0005665845,0.0002147937,0.0008498685,0.002561463,0.001371486,0.0009828556,0.0009956354,0.01825775],"category_scores_gemma":[0.001052161,0.0003680414,0.0005546549,0.0005300203,0.0004173725,0.0004742235,0.0008779002,0.0007453574,0.004734553],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02352255,"about_ca_system_score_gemma":0.06573161,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.881079,"about_ca_topic_score_gemma":0.9461173,"domain_scores_codex":[0.9987074,0.00008128489,0.00003782832,0.0001270897,0.0005569507,0.0004894558],"domain_scores_gemma":[0.9987118,0.0000342885,0.0001166067,0.00003204757,0.0005603897,0.0005448666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003448525,0.002244041,0.07925501,0.001014388,0.0001215074,0.004678968,0.003063939,0.002142172,0.1052046,0.008399903,0.4422373,0.3481897],"study_design_scores_gemma":[0.0006443164,0.002890566,0.1749651,0.0003218119,0.0001175711,0.0007978687,0.001577738,0.002104989,0.01274195,0.000448722,0.8033108,0.00007853787],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.4318328,0.007095711,0.02223837,0.04624922,0.00252389,0.02750072,0.0176126,0.002426567,0.44252],"genre_scores_gemma":[0.5268217,0.004115874,0.0180367,0.01066628,0.0005336045,0.003654137,0.01069013,0.0002573201,0.4252243],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.9764774,"threshold_uncertainty_score":0.2392426,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1939985616237188,"score_gpt":0.4307263219386791,"score_spread":0.2367277603149603,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}